| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.007.630 |
| Chemical and physical data | |
| Formula | C12H4Na5O16S4Sb |
| Molar mass | 769.10 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Stibophen is ananthelmintic originally developed byBayer that is used as a treatment forschistosomiasis[1] byintramuscular injection. It is classified as a trivalentantimony compound. Brand names include Fouadin/Fuadin (named in honor ofFuad I of Egypt, who had enthusiastically supported its research and development).[2][3]
Stibophen inhibits the enzymephosphofructokinase, which the worms need for glycolysis,[4] at least partly by binding to thesulfhydryl (–SH) group of the enzyme.[5] Inhibiting glycolysis paralyzes the worms, which lose their hold on the wall ofmesenteric veins and undergohepatic shift, die, and arephagocytosed by liver cells.[citation needed]
Thisantiinfectivedrug article is astub. You can help Wikipedia byadding missing information. |